Foxo stock forecast the biotech sector index has been

The biotech sector index has been trending upward, slightly boosting outlooks for micro-cap participants like FOXO. The forecast reflects possible sympathy rallies aligning with macro sentiment. It’s very easy to imagine that the company will have a fertile sales pipeline within the public sector. It is a less competitive sector overall, and firms that can establish their name early can thrive. FiscalNote looks like it has that potential. The reverse stock split will become effective at 4:01 PM ET on July 27, 2025. Analyst commentary suggests FOXO’s strategic positioning in longevity research gives it niche appeal. Forecasting models give moderate bullish bias if sector funding continues to rise.